1. "Cancer Cell"
Formats
  1. Journal Article (235)
  2. Editorial (34)
  3. Research Letter (6)
  4. Review (6)
  5. Correspondence (1)
  6. Miscellaneous (1)
Groups
  1. GSK Faculty (191)
  2. Department of Medicine (155)
  3. Sloan Kettering Institute Postdocs (104)
  4. Human Oncology and Pathogenesis Program (95)
  5. Solid Tumor Oncology Division (95)
  6. Sloan Kettering Institute Faculty (82)

More Groups

People
  1. Omar Abdel-Wahab (22)
  2. Ross Levine (21)
  3. Neal Rosen (15)
  4. Nikolaus Schultz (15)
  5. David Solit (13)
  6. Elisa De Stanchina (13)

More People

Years
  1. 2025 (5)
  2. 2024 (20)
  3. 2023 (14)
  4. 2022 (12)
  5. 2021 (21)
  6. 2020 (22)

More Years

Publications
  1. Cancer Cell (283)
Publishers
  1. Cell Press (283)

Results (283)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Less, but better: A simplified design for T cell redirection and conditional payload delivery
    Editorial

    Kropp, K. N.; Klebanoff, C. A.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Revealing de novo pyrimidine synthesis as a key vulnerability in brain tumors
    Editorial

    Schild, T.; Keshari, K. R.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Are we ready to look beyond plasma cells in assessing high-risk smoldering myeloma?
    Editorial

    Maclachlan, K. H.; Lesokhin, A. M.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
    Journal Article

    Nassar, A. H.; Adib, E.; Abou Alaiwi, S.; El Zarif, T.; Groha, S.; Akl, E. W.; Nuzzo, P. V.; Mouhieddine, T. H.; Perea-Chamblee, T.; Taraszka, K.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
    Editorial

    Mukherjee, S.; Carrot-Zhang, J.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and differential outcomes after immune checkpoint blockade
    Research Letter

    Hsiehchen, D.; Sfreddo, H. J.; Zhao, K.; Han, C. Y.; Morris, L. G. T.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
    Journal Article

    Lyudovyk, O.; Kim, J. Y.; Qualls, D.; Hwee, M. A.; Lin, Y. H.; Boutemine, S. R.; Elhanati, Y.; Solovyov, A.; Douglas, M.; Chen, E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
    Journal Article

    Belk, J. A.; Yao, W.; Ly, N.; Freitas, K. A.; Chen, Y. T.; Shi, Q.; Valencia, A. M.; Shifrut, E.; Kale, N.; Yost, K. E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
    Editorial

    Cherkassky, L.; Hou, Z.; Amador-Molina, A.; Adusumilli, P. S.
    Cancer Cell (2022)

    Fulltext@MSK | Save